“These new findings are based on cutoff values that directly reflect clinical practice. The results show that this improved blood test, which has previously received FDA approval and CE marking for clinical use, is just as accurate as the established cerebrospinal fluid test—detecting Alzheimer’s disease pathology with at least 90% accuracy.
“It is the first time this has been demonstrated,” says Noëlle Warmenhoven, a doctoral student in the Clinical Memory Research Unit at Lund University.